Topical iontophoretic drug delivery: Pathways, principles, factors, and skin irritation

Medicinal Research Reviews

Volumn 16, Issue 3, 1996, Pages 285-296

  Singh, Jagdish ^a   Bhatia, Kuljit S ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; INSULIN; ION; LEUPRORELIN; ZIDOVUDINE;

DRUG ADMINISTRATION; DRUG CONCENTRATION; ELECTRIC CURRENT; ELECTRICITY; ELECTRODE; HUMAN; IONTOPHORESIS; MOLECULAR SIZE; PH; PHYSICAL CHEMISTRY; REVIEW; SKIN IRRITATION; SKIN PENETRATION; TECHNIQUE; THEORY;

ADMINISTRATION, CUTANEOUS; ALGORITHMS; DERMATITIS, IRRITANT; DRUG THERAPY; HUMANS; IONTOPHORESIS; MODELS, CHEMICAL; PHARMACOKINETICS; SKIN; SKIN ABSORPTION;

EID: 0030003515     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1128(199605)16:3<285::AID-MED4>3.0.CO;2-V     Document Type: Review

References (88)

1. R. Harris, in Therapeutic Electricity and Ultraviolet Radiation, S. Litch, Ed., Wiley, Madison, 1967, p. 156.
2. J. Singh and M. S. Roberts, Drug, Design, Delivery, 4, 1 (1989).
3. J. Singh, Pharm. Sci., 1, 111 (1995).
4. J. Singh and M. S. Roberts, Pharm. Sci., 1, 223 (1995).
5. J. Singh and S. Singh, in Exogenous Dermatology: Advances in Skin Related Allergology, Bioengineering Pharmacology and Toxicology, C. Surber, P. Elsner, and A. J. Bircher, Eds., Karger, Basel, 1995.
6. S. Ganga, P. Ramarao, and J. Singh, Pharm. Res., 10, 225 (1993).
7. S. Singh and J. Singh, Med. Res. Rev., 13, 569 (1993).
8. J. Singh and H. I. Maibach, Dermatology, 187, 235 (1993).
9. P. W. Ledger, R. Gale, and S. I. Yum, in Pharmacology of the Skin, H. Mukthar, Ed., CRC Press, Boca Raton, FL, 1992, p. 73.
10. D. H. Lynch, L. K. Roberts, and R. A. Daynes, J. Control. Rel., 6, 39 (1987).
11. O. Siddiqui, M. S. Roberts, and A. E. Polack, J. Pharm. Pharmacol., 37, 732 (1985).
12. H. A. Abramson and M. G. Engel, Arch. Dermatol. Syphilol., 44, 190 (1941).
13. H. A. Abramson and H. H. Gorin, J. Phys. Chem., 44, 1094 (1940).
14. S. Grimnes, Acta Derm. Venerol. (Stockh), 64, 93 (1984).
15. L. E. Gibson and R. E. Cooke, Paediatrics., (Evanstone) 23, 545 (1959).
16. R. R. Burnette and D. Marrero, J. Pharm. Sci., 75, 738 (1986).
17. S. Del Terzo, C. R. Bhel, and R. A. Nash, Pharm. Res., 6, 85 (1989).
18. W. Magerl, R. A. Westerman, B. Mohner, and H. O. Handworker, J. Invest. Dermatol., 94, 447 (1990).
19. R. R. Burnette and B. Ongipipattanakul, J. Pharm. Sci., 77, 132 (1988).
20. R. R. Burnette and T. M. Bagniefski, J. Pharm. Sci., 77, 492 (1988).
21. C. Cullander and R. H. Guy, J. Invest. Dermatol., 97, 55 (1991).
22. C. Cullander, Adv. Drug. Delivery. Rev., 9, 119 (1992).
23. C. Cullander, R. H. Guy, and R. C. Scott, in Prediction of Percutaneous Penetration, R. H. Guy, J. Hadcraft, Eds., IBC technical services, Southhamton, to appear.
24. N. A. Monteiro-Riviere, A. O. Inman, and J. E. Riviere, Pharm. Res., 8, 141 (1991).
25. H. E. Bodde'e, I. Vandenbrink, H. K. Koerten, and F. H. N. De Hann, J. Control. Rel., 15, 227 (1991).
26. H. Sharata and R. R. Burnette, J. Pharm. Sci., 77, 27 (1989).
27. H. E. Bodde'e, N. A. M. Kruithof, J. Brusse, and H. K. Koerten, Int. J. Pharm., 53, 13 (1989).
28. N. A. Monteiro-Riviere, Fundam. Appl. Toxicol., 15, 174 (1990).
29. N. A. Monteiro-Riviere, A. O. Inman, and J. E. Reviere, Pharm. Res., 11, 251 (1994).
30. D. C. Swatzendruber, P. W. Wertz, D. J. Kitko, K. C. Madison, and D. T. Downing, J. Invest. Dermatol., 92, 251 (1989).
31. K. C. Madison, D. Swatzendruber, P. W. Wertz, and D. T. Downing, J. Invest. Dermatol., 88, 714 (1987).
32. G. K. Menon, K. R. Feingold, and P. M. Elias, J. Invest. Dermatol., 98, 279 (1992).
33. H. E. Bodde, F. H. N. de Haan, L. Kornet, W. H. M. Craanevan Hinsberg, and M. A. Salmons, Proc. Int. Symp. Control. Rel. Bioact. Mater., 18, 301 (1991).
34. H. E. Bodde, I. Van den Brink, H. K. Koerten, and F. H. N. J. de Haan, J. Control. Rel., 15, 227 (1991).
35. S. G. Shultz, in Basic Principles of Membrane Transport, Cambridge University Press, New York, 1980, p. 21.
36. D. G. Miller, Chem. Rev., 60, 15 (1960).
37. N. Lakshminarayanaiah, Chem. Rev., 65, 491 (1965).
38. Y. Kobatake, M. Yuasa, and H. Fujita, J. Phys. Chem., 72, 1752 (1968).
39. M. J. Pikal, Pharm. Res., 7, 118 (1990).
40. V. Srinivasan and W. I. Higuchi, Int. J. Pharm., 60, 133 (1990).
41. T. Masada, W. I. Higuchi, V. Srinivasan, U. Rohr, J. Fox, C. R. Bhel, and S. Pons, Int. J. Pharm., 49, 57 (1989).
42. V. Srinivasan, W. I. Higuchi, S. M. Sims, A. H. Ghanem, and C. R. Bhel, J. Pharm. Sci., 78, 370 (1989).
43. J. B. Phips, R. V. Padmanabhan, and G. A. Lattin, J. Pharm. Sci., 78, 365 (1989).
44. B. H. Sage, Jr. and J. E. Rivirer, Adv. Drug Deliv. Rev., 9, 265 (1992).
45. W. R. Lieb and W. D. Stein, J. Membrane Biol., 92, 111 (1986).
46. E. M. Renkin, J. Physiol., 38, 225 (1955).
47. N. H. Yoshida and M. S. Roberts, Adv. Drug Deliv. Rev., 9, 239 (1992).
48. M. S. Roberts, J. Singh, N. H. Yoshida, and K. I. Currie, in Prediction of Percutaneous Absorption, R. E. Scott, R. H. Guy, J. Hadcraft, Eds., IBC Technical Services, London, 1990, p. 231.
49. P. G. Green, R. S. Hinz, A. Kim, F. C. Szoka, and R. H. Guy, Pharm. Res., 8, 1121 (1991).
50. S. Del Terzo, C. R. Bhel, and R. A. Nash, Pharm. Res., 6, 85 (1989).
51. P. Lelawongs, J. Liu, O. Siddiqui, and Y. W. Chien, Int. J. Pharm., 53, 13 (1989).
52. L. Wearly, J. C. Liu, and Y. W. Chien, J. Control. Rel., 8, 237 (1989).
53. L. L. Miller and G. A. Smith, J. Pharm. Sci., 49, 15 (1989).
54. N. H. Bellantone, S. Rim, M. I. Francoeur, and B. Rasadi, Int. J. Pharm., 30, 63 (1986).
55. J. E. Sanderson, S. de Reil, and R. Dixon, J. Pharm. Sci., 78, 361 (1989).
56. G. B. Kasting and K. C. Keister, J. Control. Rel., 8, 210 (1989).
57. G. B. Kasting, E. W. Merritt, and J. C. Kiester, J. Membrane Sci., 35, 137 (1988).
58. J. B. Phipps, J. M. Sunram, and R. V. Padmanabhan, Proc. Int. Symp. Control. Rel. Bioact. Mater., 16, 50 (1989).
59. J. B. Phipps and J. R. Gyory, Adv. Drug Deliv. Rev., 9, 137 (1992).
60. S. M. Sims and W. I. Higuchi, J. Membrane Sci., 49, 305 (1990).
61. O. Siddiqui, Y. Sun, J. C. Liu, and J. C. Chien, J. Pharm. Sci., 76, 341 (1987).
62. J. D. Middleton, Brit. J. Dermatol., 81 (suppl. 4), 56 (1969).
63. H. Molitor and L. Fernandez, J. Med. Sci., 198, 778 (1939).
64. M. J. Pikal and S. Shah, Pharm. Res., 7, 213 (1990).
65. V. Srinivasan, M. H. Su, W. I. Higuchi, and C. R. Behl, J. Pharm. Sci., 79, 588 (1990).
66. J. Singh, Pharmazie., 45, 634 (1990).
67. Y. W. Chien, O. Siddiqui, Y. Sun, W. M. Shi, and J. C. Liu, Biological Approaches to the Controlled Delivery of Drugs, Acad. Sci., New York, 1988, p. 32.
68. L. P. Gangarosa, N. H. Park, B. C. Fong, D. F. Scott, and J. M. Hill, J. Pharm. Sci., 67, 1439 (1978).
69. L. Wearly, L. C. Liu, and Y. W. Chien, J. Control. Rel., 9, 231 (1989).
70. A. D. Emanulele and J. N. Stainforth, Pharm. Res., 8, 913 (1991).
71. S. Singh, S. B. Jayaswal, S. N. Upadhyay, and J. Singh, J. Control. Rel., 18, 165 (1992).
72. H. A. Abramson and M. H. Gorin, J. Allergy, 12, 169 (1992).
73. P. G. Green, M. Flanagan, B. Shroot, and R. Guy, Pharm. Res., to appear.
74. J. E. Sanderson, R. W. Caldwell, J. Hsaio, R. Dixin, and R. R. Tuttle, J. Pharm. Sci., 76, 215 (1987).
75. J. E. Sanderson and S. de Riel, U.S. Patent, 4, 722 (1988).
76. K. Okabe, H. Yamaguchi, and Y. Kawai, J. Control. Rel., 4, 79 (1986).
77. T. Bagniefski and R. R. Burnette, J. Control. Rel., 11, 113 (1990).
78. L. Wearly, Y. W. Chien, Pharm. Res., 7, 34 (1990).
79. P. W. Ledger, Adv. Drug Deliv. Rev., 9, 289 (1992).
80. J. Singh, M. Gross, M. O'Conell, B. Sage, and H. I. Maibach, Pharm. Res., 10, 5 (1994).
81. J. Singh, M. Gross, M. O'Conell, B. Sage, and H. I. Maibach, Proc. Int. Symp. Control. Rel. Bioact. Mater., 21, 365 (1994).
82. C. J. Dalsgaard, J. Jernbeck, W, Stains, J. Kjartasson, A. Haegerstrand, T. Hokfelt, E. Brodin, A. C. Cuello, and J. C. Brown, Histochemistry, 91, 35 (1989).
83. U. Nannmark, F. Buch, and T. Alberktsson, Acta Orthp. Scand., 56, 52 (1985).
84. D. L. Kellog, J. M. Jonson, and W. A. Kosiba, Am. J. Physiol., 257, H1599 (1989).
85. R. P. Tuckett, J. Invest. Dermatol., 79, 368 (1982).
86. J. E. Sanderson, S. DeReil, and R. Dixon, J. Pharm. Sci., 78, 361 (1989).
87. L. P. Gangarosa and W. P. Baker, Southwestern Pharmacology Society Program Presentation and Abstracts, 9, 24 (1988).
88. Instruction Guides to the Phoresor II Iontophoretic drug delivery system and Ioflex EL 502 Iontophoretic electrode, Iomed Inc., Salt Lake City, UT, 1988.